Evidence map›Paper›PMID 27059426›Full record

ArticleChembiochem : a European journal of chemical biology2016

DNA Walker-Regulated Cancer Cell Growth Inhibition.

Feiran Li, Tae-Gon Cha, Jing Pan, Altug Ozcelikkale, Bumsoo Han, Jong Hyun Choi

Open access · greenAbstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 25 citations in OpenAlex.

  1. DNA Origami-Cyanine Nanocomplex for Precision Imaging of KRAS-Mutant Pancreatic Cancer Cells.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. Regeneration of Burnt Bridges on a DNA Catenane Walker.Angewandte Chemie (International ed. in English) · 2020
    Article
  6. Dynamic DNA Assemblies in Biomedical Applications.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2020
    Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Feiran LiSchool of Mechanical Engineering, Purdue University, West Lafayette, IN, 47907, USA.
Tae-Gon ChaSchool of Mechanical Engineering, Purdue University, West Lafayette, IN, 47907, USA.
Jing PanSchool of Mechanical Engineering, Purdue University, West Lafayette, IN, 47907, USA.
Altug OzcelikkaleSchool of Mechanical Engineering, Purdue University, West Lafayette, IN, 47907, USA.
Bumsoo HanSchool of Mechanical Engineering, Purdue University, West Lafayette, IN, 47907, USA.
Jong Hyun ChoiSchool of Mechanical Engineering, Purdue University, West Lafayette, IN, 47907, USA. jchoi@purdue.edu.
Purdue University West Lafayette · US

Funding

Indiana Clinical and Translational Sciences InstituteUL1TR001108 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI DENNE, SCOTT C., SHEKHAR, ANANTHA · 2013 to 2017
$23.3M
Indiana Clinical and Translational Science Institute (UL1)UL1TR000006 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI SHEKHAR, ANANTHA · 2012 to 2013
$5.6M
NCATS NIH HHS UL1 TR000006NCATS NIH HHS UL1 TR001108
6 · The paper itself

Abstract

We demonstrate a DNAzyme-based walker system as a controlled oligonucleotide drug AS1411 release platform for breast cancer treatment. In this system, AS1411 strands are released from fuel strands as a walker moves along its carbon nanotube track. The release rate and amount of anticancer oligonucleotides are controlled by the walker operation. With a walker system embedded within the collagen extracellular matrix, we show that this drug release system can be used for in situ cancer cell growth inhibition.

Indexed as

Antineoplastic AgentsAptamers, NucleotideCell Line, TumorCell SurvivalCollagenDNA, CatalyticExtracellular MatrixHumansMCF-7 CellsOligodeoxyribonucleotidesQuantum DotsAGRO 100Antineoplastic AgentsAptamers, NucleotideCollagenDNA, CatalyticOligodeoxyribonucleotidesanticancerDNA walkerDNAzymegrowth inhibitionoligonucleotides

Identifiers

PMID27059426
PMCPMC5051347
OpenAlexW2323151162

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.